Scalper1 News
Generic and specialty drugmaker Actavis agreed to acquire Allergan for more than $66 billion on Monday, potentially creating a pharmaceutical giant with $23 billion in annual sales and a market cap around $147 billion. Actavis (ACT) will pay $129.22 plus 0.3683 Actavis share for each share of Allergan (AGN). That’s equal to $220.54 based on Monday’s closing price. It is appreciably above the hostile bid that Valeant Pharmaceuticals Scalper1 News
Scalper1 News